Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Umar Ndagi
Observed names:
Ndagi U,
Ndagi, Umar,
U Ndagi
Observed institutions:
Nasarawa State University,
Niger State Ministry of Health,
Ibrahim Badamasi Babangida University,
Federal University of Technology Minna,
University of KwaZulu-Natal
ORCID:
0000-0001-5239-2227
Observed ORCID:
0000-0001-5239-2227
OpenAlex ID:
A5038995237
Metal complexes in cancer therapy – an update from drug design perspective
2017
·
Umar Ndagi
, Ndumiso Mhlongo
, et al.
·
Drug Design Development and Therapy
·
935
PDF
Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
2020
·
Umar Ndagi
, Abubakar A. Falaki
, et al.
·
RSC Advances
·
76
PDF
The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design
2017
·
Umar Ndagi
, Ndumiso N Mhlongo
, et al.
·
Molecular BioSystems
·
58
Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study
2023
·
Hussaini Majiya
, Mohammed Aliyu-Paiko
, et al.
·
JMIRx Med
·
53
PDF
Density functional theory study of gold(III)-dithiocarbamate complexes with characteristic anticancer potentials
2020
·
Monsurat M. Lawal
, Isiaka A. Lawal
, et al.
·
Journal of Inorganic Biochemistry
·
21
DFT Study of the Structural and Electronic Properties of Selected Organogold(III) Compounds with Characteristic Anticancer Activity
2019
·
Umar Ndagi
, Monsurat M. Lawal
, et al.
·
Russian Journal of Physical Chemistry A
·
20
Emergence of a Promising Lead Compound in the Treatment of Triple Negative Breast Cancer: An Insight into Conformational Features and Ligand Binding Landscape of c-Src Protein with UM-164
2017
·
Umar Ndagi
, Ndumiso N. Mhlongo
, et al.
·
Applied Biochemistry and Biotechnology
·
14
An analogue of a kinase inhibitor exhibits subjective characteristics that contribute to its inhibitory activities as a potential anti-cancer candidate: insights through computational biomolecular modelling of UM-164 binding with lyn protein
2019
·
Umar Ndagi
, Maryam Abdullahi
, et al.
·
RSC Advances
·
13
PDF
Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase—a molecular modelling perspective
2022
·
Ntombikayise Tembe
, Kgothatso E. Machaba
, et al.
·
Journal of Molecular Modeling
·
10
PDF
Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment
2021
·
Fatima Y. Adeowo
, Tosin P. Oyetunji
, et al.
·
Chemistry & Biodiversity
·
10
Computational studies of potential antiviral compounds from some selected Nigerian medicinal plants against SARS-CoV-2 proteins
2023
·
Raymond C. Ibeh
, Gavin C. Ikechukwu
, et al.
·
Informatics in Medicine Unlocked
·
7
A consequence of drug targeting of aminoacyl‐tRNA synthetases in Mycobacteriumtuberculosis
2021
·
Umar Ndagi
, Hezekiel M. Kumalo
, et al.
·
Chemical Biology & Drug Design
·
7
Re-emergence of an orphan therapeutic target for the treatment of resistant prostate cancer – a thorough conformational and binding analysis for ROR-γ protein
2016
·
Umar Ndagi
, Ndumiso N. Mhlongo
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
7
Impact of Tenofovir/Lamivudine/Dolutegravir (Tld) on the Health-Related Quality of Life and Clinical Outcomes of HIV/AIDS Patients at a Tertiary Health Facility in Niger State
2020
·
Danjuma Umar
, Bala Waziri
, et al.
·
Research Square
·
4
PDF
Drug repurposing approach against Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase: insight from molecular dynamics simulations
2021
·
Kimona Kisten
, Hezekiel M. Kumalo
, et al.
·
Molecular Simulation
·
3
Nanozeolites: eco-friendly materials for healthcare applications
2025
·
Fatima Gogo Mayaki
, Abdulsalami Sanni Kovo
, et al.
·
Physica Scripta
·
1
Qualitative Assessment of the Use of Big Data and Big Data Tools in the Prevention of Epidemiological Diseases’ Spread Through Airports
2025
·
ENDURANCE AJODO
, I. A Kuti
, et al.
·
Research Square
·
1
PDF
Impact of Drug Repurposing on SARS-Cov-2 Main Protease
2022
·
Umar Ndagi
, Maryam Abdullahi
, et al.
·
Russian Journal of Physical Chemistry A
·
1
PDF
Metal complexes in cancer therapy – an update from drug design perspective
2017
·
Ndagi U
, Mhlongo N
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
1
ACS POSTER Dr. Maryam (1)
2026
·
Abdullahi, Maryam
, Ndagi, Umar
, et al.
Phylogenetic Analysis of Pleurotus Tuber-Regium Across Selected African Regions
2025
·
Zainab Adamu
, Emmanuel Olofu Ogbadoyi
, et al.
·
Sahel Journal of Life Sciences FUDMA
Authors’ Response to Peer Reviews of “Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study”
2023
·
Hussaini Majiya
, Mohammed Aliyu-Paiko
, et al.
·
JMIRx Med
PDF
In silico screening of W. salutaris bioactive constituents reveal betulinic acid, ursolic acid acetate and eucosterol as potential M. tuberculosis antagonists targeting FabF
2021
·
Nokukhanya Gumede
, Kgothatso E. Machaba
, et al.
·
Research Square
PDF
Insight into cancer targets and ligand binding landscape using bioinformatics and integrated molecular modeling tools.
2017
·
Umar Ndagi
·
ResearchSpace (University of KwaZulu-Natal)
Show more works
View as search
Works count:
25
Citation count:
1,241
H-index:
10
I10-index:
10
Year
Topic
Type